Any stock with a solid potential for growth makes a good pick for ... The purchased brought fedratinib into Celgene's fold. Celgene plans to file for FDA approval of fedratinib in treating myelofibrosis in mid-2018. The company announced an …
LONDON: European stock markets retreated Wednesday after Asia closed mostly ... the Swiss-based company said its net profit last year hit $5.7 billion (4.6 …
Investors in Amicus Therapeutics Inc (Symbol: FOLD) saw new options become available today, for the March 2nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the FOLD options chain for the …
NASDAQ1mon
Amicus Therapeutics, Inc. (NASDAQ:FOLD) stock was flying high today on positive news from the U.S. Food and Drug Administration (FDA). Source: Shutterstock Amicus Therapeutics, Inc. says that the FDA is allowing it to submit a new …
Stocks of Canada’s largest pot producers have lost their momentum of the past year when their prices surged more than three-fold. Despite yesterday’s jump, …
The value of stocks traded by local investors increased almost five-fold from a year earlier last month, according to the Accra-based Central Securities Depository …
I’ll admit, it’s not the most confidence-inspiring headline. Still, with Tapco furniture’s reputation it’s the most positive headline I could write, without risking the accusation of being on their payroll. In many cases, Tapco’s reputation as a ...
I just stumbled upon an incredibly constructive-looking chart within a very lucrative sector. I am not going to beat about the bush, the investment that contains this incredibly constructive stock chart is Amicus Therapeutics, Inc. (NASDAQ: …
There’s a good chance these issues pretty swiftly disappear once Diego Chara is back in the fold, but it hasn’t been a repeat of the tremendous preseason that …
Amicus Therapeutics, Inc. says that the FDA is allowing it to submit a new drug application for migalastat. This is the company’s oral precision medicine to treat Fabry disease. FOLD stock is on the rise after the company said it will …